Key facts
- It has raised $9.5M; the latest was Later Stage VC in Oct 2025.
- Notable investors include Keiretsu Forum, Highcroft Capital, MTPConnect, Perennial Partners (Funds and Trusts).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for VenstraMedical
- ·The full record, as it builds
Funding rounds
No funding rounds for VenstraMedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VenstraMedical
Developer of a medical device designed to offer temporary cardiac support to patients suffering from cardiogenic shock or hemodynamic compromise. The company's device is a transcatheter heart pump that is designed to be delivered into the heart via a catheter without the need for surgery, enabling doctors to provide rapid life-sustaining support for patients.
- Sector
- Healthcare
- HQ
- Newcastle, Australia
- Founded
- 2018
- Employees
- 4
- Website
- venstramedical.com/
- Ownership
- Privately Held (backing)
VenstraMedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VenstraMedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VenstraMedical in its N-PORT filings yet. We sweep new filings monthly.